La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Neuroimaging »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroglia < Neuroimaging < Neuroleptic Malignant Syndrome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000121 (2016) Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada]The role of biomarkers and imaging in Parkinson's disease.
000204 (2016) A Jon Stoessl [Canada] ; Martin J. Mckeown [Canada]Movement disorders.
000206 (2016) I. Aracil-Bola Os [Canada] ; A P Strafella [Canada]Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.
000213 (2016) Oury Monchi [Canada] ; Alexandru Hanganu [Canada] ; Pierre Bellec [Canada]Markers of cognitive decline in PD: The case for heterogeneity.
000498 (2015) Sarah Coakeley [Canada] ; Antonio P. StrafellaImaging pathological tau in atypical parkinsonian disorders.
000501 (2015) Yuko Koshimori [Canada] ; Ji-Hyun Ko [Canada] ; Romina Mizrahi [Canada] ; Pablo Rusjan [Canada] ; Rostom Mabrouk [Canada] ; Mark F. Jacobs [Canada] ; Leigh Christopher [Canada] ; Clement Hamani [Canada] ; Anthony E. Lang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.
000568 (2015) Grace Lee [Canada] ; Adrian C. Byram [Canada] ; Adrian M. Owen [Canada] ; Urs Ribary [Canada] ; A Jon Stoessl [Canada] ; Andrea Townson [Canada] ; Christine Stables [Canada] ; Judy Illes [Canada]Canadian perspectives on the clinical actionability of neuroimaging in disorders of consciousness.
000579 (2015) Joseph J. Locascio [États-Unis] ; Shirley Eberly [États-Unis] ; Zhixiang Liao [États-Unis] ; Ganqiang Liu [États-Unis] ; Ashley N. Hoesing [États-Unis] ; Karen Duong [États-Unis] ; Ana Trisini-Lipsanopoulos [États-Unis] ; Kaltra Dhima [États-Unis] ; Albert Y. Hung [États-Unis] ; Alice W. Flaherty [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Michael T. Hayes [États-Unis] ; Anne-Marie Wills [États-Unis] ; U. Shivraj Sohur [États-Unis] ; Nicte I. Mejia [États-Unis] ; Dennis J. Selkoe [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Xianjun Dong [États-Unis] ; Ken Marek [États-Unis] ; Bin Zheng [États-Unis] ; Adrian Ivinson [États-Unis] ; Bradley T. Hyman [États-Unis] ; John H. Growdon [États-Unis] ; Lewis R. Sudarsky [États-Unis] ; Michael G. Schlossmacher [États-Unis] ; Bernard Ravina [Canada] ; Clemens R. Scherzer [États-Unis]Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.
000709 (2014) Lucia Ricciardi [Royaume-Uni] ; Carla Piano [Italie] ; Anna Rita Bentivoglio [Italie] ; Alfonso Fasano [Canada]Long-term effects of pedunculopontine nucleus stimulation for Pisa syndrome.
000732 (2014) Sarah Christine Lidstone [Canada]Great expectations: the placebo effect in Parkinson's disease.
000735 (2014) Cristina Nombela [Oman] ; James B. Rowe [Royaume-Uni] ; Sophie E. Winder-Rhodes [Royaume-Uni] ; Adam Hampshire [Royaume-Uni] ; Adrian M. Owen [Canada] ; David P. Breen [Royaume-Uni] ; Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo [Australie] ; Alison J. Yarnall [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; David J. Brooks [Danemark] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
000847 (2013) Patrick S R. Davidson [Canada] ; Shaun P. Cook ; Leslie Mcghan ; Thomas Bouchard ; Richard CamicioliSource memory in normal aging and Parkinson's disease.
000887 (2013) Leigh Christopher [Canada] ; Antonio P. StrafellaNeuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
000913 (2013) Nicola J. Ray [Canada] ; Antonio P. StrafellaImaging impulse control disorders in Parkinson's disease and their relationship to addiction.
000948 (2013) Pankaj A. Agarwal [Canada] ; A Jon StoesslBiomarkers for trials of neuroprotection in Parkinson's disease.
000963 (2013) Kelly S G. Aminian [Canada] ; Antonio P. StrafellaAffective disorders in Parkinson's disease.
000968 (2013) Abdul Qayyum Rana [Canada] ; Mohamed Sufian Masroor ; Atif Saeed KhanA review of methods used to study cognitive deficits in Parkinson's disease.
000985 (2012) Nicola J. Ray [Canada] ; Antonio P. StrafellaThe neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.
000A25 (2012) Oury Monchi [Canada] ; Clotilde Degroot ; Beatriz Mejia-Constain ; Marie-Andrée BruneauNeuroimaging studies of different cognitive profiles in Parkinson's disease.
000A26 (2012) A Jon Stoessl [Canada]Neuroimaging in Parkinson's disease: from pathology to diagnosis.
000A67 (2012) Thien Thanh Dang-Vu [Canada] ; Jean-François Gagnon ; Mélanie Vendette ; Jean-Paul Soucy ; Ronald B. Postuma ; Jacques MontplaisirHippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Neuroimaging" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Neuroimaging" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neuroimaging
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022